Needham Maintains Buy on Pulse Biosciences, Raises Price Target to $64

Benzinga · 2d ago
Needham analyst Mike Matson maintains Pulse Biosciences (NASDAQ:PLSE) with a Buy and raises the price target from $58 to $64.